Fleischmann, R., Mysler, E., Hall, S., Kivitz, A. J., Moots, R. J., Luo, Z., DeMasi, R., Soma, K., Zhang, R., Takiya, L., Tatulych, S., Mojcik, C., Krishnaswami, S., Menon, S., Smolen, J. S., & , (2017). efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial. Lancet, 390(10093), 457–468. http://access.bl.uk/ark:/81055/vdc_100049765650.0x000017